Acorah Software Products - Accounts Production 18.1.200 false true 30 November 2024 1 December 2023 false 1 December 2024 30 November 2025 30 November 2025 12308702 Dr S J Osborn iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 12308702 2024-11-30 12308702 2025-11-30 12308702 2024-12-01 2025-11-30 12308702 frs-core:CurrentFinancialInstruments 2025-11-30 12308702 frs-core:ShareCapital 2025-11-30 12308702 frs-core:RetainedEarningsAccumulatedLosses 2025-11-30 12308702 frs-bus:PrivateLimitedCompanyLtd 2024-12-01 2025-11-30 12308702 frs-bus:FilletedAccounts 2024-12-01 2025-11-30 12308702 frs-bus:SmallEntities 2024-12-01 2025-11-30 12308702 frs-bus:AuditExempt-NoAccountantsReport 2024-12-01 2025-11-30 12308702 frs-bus:SmallCompaniesRegimeForAccounts 2024-12-01 2025-11-30 12308702 frs-bus:Director1 2024-12-01 2025-11-30 12308702 frs-countries:EnglandWales 2024-12-01 2025-11-30 12308702 2023-11-30 12308702 2024-11-30 12308702 2023-12-01 2024-11-30 12308702 frs-core:CurrentFinancialInstruments 2024-11-30 12308702 frs-core:ShareCapital 2024-11-30 12308702 frs-core:RetainedEarningsAccumulatedLosses 2024-11-30
Registered number: 12308702
S J Osborn Pathology Ltd
Unaudited Financial Statements
For The Year Ended 30 November 2025
S J Osborn Pathology Ltd
Contents
Contents

| Page
--- | ---
Balance Sheet | 1
Notes to the Financial Statements | 2

Page 1
S J Osborn Pathology Ltd
Balance Sheet
As At 30 November 2025
Balance Sheet
Registered number: 12308702

| 2025 | 2024
--- | --- | ---
| Notes | £ | £ | £ | £
CURRENT ASSETS
Cash at bank and in hand |  | 26,330 |  | 21,792 |
|  | 26,330 |  | 21,792 |
Creditors: Amounts Falling Due Within One Year | 4 | (4,016 ) |  | (4,265 ) |
NET CURRENT ASSETS (LIABILITIES) |  |  | 22,314 |  | 17,527
TOTAL ASSETS LESS CURRENT LIABILITIES |  |  | 22,314 |  | 17,527
NET ASSETS |  |  | 22,314 |  | 17,527
CAPITAL AND RESERVES
Called up share capital | 5 |  | 100 |  | 100
Profit and Loss Account |  |  | 22,214 |  | 17,427
SHAREHOLDERS' FUNDS |  |  | 22,314 |  | 17,527

For the year ending 30 November 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.
On behalf of the board

Dr S J Osborn Director
13/04/2026

The notes on page 2 form part of these financial statements.
Page 1
Page 2
S J Osborn Pathology Ltd
Notes to the Financial Statements
For The Year Ended 30 November 2025
Notes to the Financial Statements
1. General Information
S J Osborn Pathology Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 12308702 . The registered office is 2 Wike Lane, Bardsey, Leeds, LS17 9EB.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
2.2. Turnover
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services. Turnover is reduced for estimated customer returns, rebates and other similar allowances.
2.3. Taxation
Income tax expense represents the sum of the tax currently payable and deferred tax.
The tax currently payable is based on taxable profit for the year. Taxable profit differs from profit as reported in the statement of comprehensive income because of items of income or expense that are taxable or deductible in other year and items that are never taxable or deductible. The company's liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the end of the reporting period.
3. Average Number of Employees
Average number of employees, including directors, during the year was: NIL (2024: NIL)
- -
4. Creditors: Amounts Falling Due Within One Year

| 2025 |  | 2024
--- | --- | --- | ---
| £ |  | £
Corporation tax | 1,240 |  | 1,205
Accruals and deferred income | 616 |  | 610
Director's loan account | 2,160 |  | 2,450
| 4,016 |  | 4,265

5. Share Capital

| 2025 |  | 2024
--- | --- | --- | ---
| £ |  | £
Allotted, Called up and fully paid | 100 |  | 100

Page 2